2021-12-31 09:11:00 BdST
EIB provides $283m for Bangladesh’s healthcare development
European Investment Bank (EIB) has provided Bangladesh $283.06 million (EUR 250 million) to purchase Covid-19 vaccine and strengthen the healthcare system.
A finance contract (FC) was signed in this regard between Bangladesh and EIB under a project titled “Bangladesh Covid-19 Public Health Programme”.
Economic Relations Division (ERD) Secretary Fatima Yasmin and EIB Head of Asia and Pacific Division Edvardas Bumsteinas and EIB Legal Counsel Imanol Lecue Gurtubay, signed the loan agreement on behalf of Bangladesh and EIB respectively.
The main objectives of the finance programme are to purchase and supply vaccines for the prevention of Covid-19 infections, strengthen the healthcare system and expand social security in the health sector.
It’s a concessional loan to the government of Bangladesh, with a repayment period of twenty years, including five years’ grace period.
"This is their first-ever highest contribution as part of their development cooperation to our country,” Yasmin said.
EIB is an important development partner of Bangladesh. It co-financed four projects along with ADB amounting to $423 million (USD) in railway and water treatment plants of Dhaka Wasa.
Unlike the previous co-financed contribution, this is the first time standalone contribution for Bangladesh.
Unauthorized use or reproduction of The Finance Today content for commercial purposes is strictly prohibited.